The Ogretmen laboratory screened previously reported microarray data sets of several human tumor tissues (metastatic head and neck
squamous cell carcinoma, melanoma, and renal
cell carcinoma) and showed that, in these
samples, only the levels of CerS4 were significantly decreased.